Equity Details
Price & Market Data
Price: $0.41
Daily Change: $0.00 / 0.00%
Daily Range: $0 - $0
Market Cap: $43,076,480
Daily Volume: 0
Performance Metrics
1 Week: -2.79%
1 Month: -3.28%
3 Months: 14.79%
6 Months: 77.45%
1 Year: 122.0%
YTD: 27.44%
About Biomark Diagnostics Inc. (BMKDF)
Financial insights into Biomark Diagnostics Inc. (BMKDF). Current price: 0.41, daily change: $0.00 / 0.00%. Market cap: 43,076,480. Performance metrics across all timeframes are updated.
Details
Biomark Diagnostics Inc. develops early-stage cancer diagnostic technology platform to detect and treat cancer. The company invests in and develops a liquid biopsy metabolic panel assay for the early-stage diagnosis of lung cancer, as well as glioblastoma (GBM), breast cancer, and head and neck cancer. It is also developing liquid biopsy tests for various cancer types, including glioblastoma, gastrointestinal, prostate, head, neck cancers. The company was incorporated in 2014 and is headquartered in Richmond, Canada.